Brooklyn Hospital Center Hematology and Medical Oncology

Topics

• Lymphoma Diagnosis and Treatment 12
• Pancreatic and Hepatic Oncology Research 10
• Venous Thromboembolism Diagnosis and Management 10
• Prostate Cancer Diagnosis and Treatment 9
• Breast Cancer Treatment Studies 8
• Esophageal Cancer Research and Treatment 7
• Hemoglobinopathies and Related Disorders 7
• CAR-T cell therapy research 6
• Complement system in diseases 6
• Sarcoma Diagnosis and Treatment 5
• Cancer Diagnosis and Treatment 3
• Chronic Lymphocytic Leukemia Research 3

Most cited

1. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.

   The Lancet. Oncology · 2023 · 629 citations · Sonal Bordia

2. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 206 citations · Sonal Bordia

3. First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.

   Cancer discovery · 2021 · 225 citations · Sonal Bordia

4. KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma.

   Future oncology (London, England) · 2021 · 121 citations · Sonal Bordia

5. Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 22 citations · Sonal Bordia

6. JASPER: Phase 2 trial of first-line niraparib plus pembrolizumab in patients with advanced non-small cell lung cancer.